Oncology & Cancer

New potential immunotherapies for pancreatic cancer

Pancreatic cancer can be a devastating diagnosis due to its extremely aggressive nature and low survival rate. But there may be hope on the horizon thanks to scientists at RUSH who have discovered two new targets for decreasing ...

Medications

Study questions benefit of new Alzheimer's drug

Last summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer's. But new research from the University of Georgia suggests that patients and caregivers may not experience ...

page 2 from 40